Shares of Relmada Therapeutics RLMD rallied 42% in a week after the company announced positive 12-month interim data from its ongoing mid-stage study evaluating NDV-01 in patients with high-risk ...
Zscaler, Inc. ZS shares have plunged 33.7% over the past three months, underperforming the Zacks Computer and Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results